January 2021 Archives by thread
Starting: Sat Jan 2 03:24:00 PST 2021
Ending: Wed Jan 27 02:48:29 PST 2021
Messages: 39
- [Ip-health] The Delhi high court on Thursday restrained Sci Hub and Libgen, two online repositories providing free access to paywalled research
leena menghaney
- [Ip-health] Russian Government Grants Compulsory License for Remdevisir
James Love
- [Ip-health] GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration
Katy Athersuch
- [Ip-health] Last call for applications: MPP looking for two new Board Members
Sophie Thievenaz
- [Ip-health] NIST requests comment on proposal to weaken march-in rights
Zain Rizvi
- [Ip-health] Politico: MEP Canfin to Commission: We need more details on CureVac vaccine contract
Thiru Balasubramaniam
- [Ip-health] WHO informal consultation (3 December 2020) addressed concerns on price transparency and shortages
Thiru Balasubramaniam
- [Ip-health] New South Centre Paper: Reconsidérations sur la fabrication mondiale et locale de produits médicaux après le COVID-19
Anna Bernardo
- [Ip-health] MSF blog: will history repeat itself? rebutting pharma's rejection of a global COVID-19 IP waiver
Yuanqiong HU
- [Ip-health] RIS Webinar on19th Jan-Innovation and Access in Vaccines, and Health Impact Fund
ravi srinivas
- [Ip-health] RIS Webinar on 19th 6.30 PM IST Innovation & Access in Vaccines, & Health Impact Fund
ravi srinivas
- [Ip-health] HAI statement at EB148 14.1 WHO Covid-19 response
Jaume Vidal
- [Ip-health] WHO EB 148: Oral statement of Knowledge Ecology International on the COVID-19 response
Thiru Balasubramaniam
- [Ip-health] Online discussion of NIST proposals to change Bayh-Dole regulations and statutes – January 27, 2021 at 2PM
Claire Cassedy
- [Ip-health] EB 148: WHO’s COVID-19 Technology Access Pool (C-TAP) comes under scrutiny
Thiru Balasubramaniam
- [Ip-health] NEW South Centre Policy Brief: Repenser la R&D pour les produits pharmaceutiques après le choc du nouveau coronavirus COVID-19
Anna Bernardo
- [Ip-health] The USA rejoins the WHO, plans to join COVAX and support the ACT-Accelerator
Susan Isiko Strba
- [Ip-health] Letter from the People’s Vaccine Alliance and Health Action International to Dr. Tedros on C-TAP
Thiru Balasubramaniam
- [Ip-health] Statement: Biden, go bigger on COVID-19 vaccines
Peter Maybarduk
- [Ip-health] The European Commission-Curevac Advance Purchase Contract for a COVID-19 Vaccine
Claire Cassedy
- [Ip-health] ONE welcomes calls for suspension of patents on COVID vaccines
Claire Cassedy
- [Ip-health] The Guardian: WHO platform for pharmaceutical firms unused since pandemic began
Thiru Balasubramaniam
- [Ip-health] HAI statement at EB148 7 Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices
Jaume Vidal
- [Ip-health] HAI statement at EB148 8 Global strategy and plan of action on public health, innovation and intellectual property
Jaume Vidal
- [Ip-health] TWN Info: COVID-19: Global “moral failure” in distribution of vaccines, says WHO DG
Sangeeta Shashikant
- [Ip-health] TWN Info: Opponents of TRIPS waiver asked to respond to questions by proponents
Sangeeta Shashikant
- [Ip-health] TRIPS Waiver update at WTO
Priti Patnaik
- [Ip-health] WHO EB 148: KEI’s statement on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies
Thiru Balasubramaniam
- [Ip-health] EB 148: KEI’s statement on WHO’s Global Observatory on Health R&D
Thiru Balasubramaniam
- [Ip-health] EB 148: China and the United Kingdom raise concerns over the WHO Foundation and other WHO initiatives
Thiru Balasubramaniam
- [Ip-health] Webinar 26 January: Vaccine democracy and the role of local civil societies
Heesob Nam
- [Ip-health] The Lancet: CEPI Criticised for Lack of Transparency
Peter Maybarduk
- [Ip-health] TWN Info: Proponents of TRIPS waiver call for text-based negotiations
Sangeeta Shashikant
- [Ip-health] The Guardian: EU threatens to block Covid vaccine exports amid AstraZeneca shortfall
Thiru Balasubramaniam
- [Ip-health] Wed discuss of proposed changes in Bayh-Dole Act regulations and Stevenson-Wydler Act statutes
James Love
- [Ip-health] Agenda: Jan 27, 2020 Discussion of proposals to change Bayh-Dole regulations and Stevenson-Wydler Act statutes
James Love
- [Ip-health] Politico: Europe faces identity crisis over vaccine trade war - Free-trading Eurocrats want to avoid protectionism but are facing strong political headwinds.
Thiru Balasubramaniam
- [Ip-health] NEW South Centre Investment Policy Brief: Countries’ Policy Space to Implement Tobacco Packaging Measures: Revisiting the Philip Morris v. Uruguay Case
Anna Bernardo
Last message date:
Wed Jan 27 02:48:29 PST 2021
Archived on: Wed Jan 27 02:54:43 PST 2021
This archive was generated by
Pipermail 0.09 (Mailman edition).